Q3, 2010
This report contains data from a survey of 105 central lab decision-makers from North America, Europe, and Asia representing. Decision-makers represent 77 different biopharma companies and provide views to their outsourcing and service provider selection strategies, as well as their spending for central lab services. Participants also provide insight into which services are likely to be in the highest demand through 2013 and their intentions for sole provider partnerships.
What you will learn:
- For Sponsors
- How 7 service providers perform across critical service attributes
- The attributes your peers use to select and evaluate their vendors
- The adoption of sole source central lab partnerships
- For Service Providers
- The market size for outsourced central lab services
- The areas where sponsors see the most growth
- Which attributes are most important to your customers when selecting a service provider
- Preferred provider, sole source, and regional pharma activity
Report Contents:
- Market Dynamics and Outsourcing Environment – This section discusses, from sponsors’ perspectives, which central labs services are likely to drive growth in the coming years; which global regions are increasing and decreasing in strategic importance; growth in “sole-provider” outsourcing; and sizes the market for outsourced central labs services.
- Service Provider Evaluations – This section provides an analysis of how central labs service providers are selected; how the top central labs providers perform, relative to their customers’ expectations; analyses of what drives satisfaction in central labs relationships; and central labs providers’ strengths and weaknesses; what can differentiate providers from each other; and the importance of specific metrics that labs providers might consider tracking and reporting going forward.